The Institute for Medical Technology Assessment Productivity Cost Questionnaire (iPCQ) and the Medical Consumption Questionnaire (iMCQ): Translation and Cognitive Debriefing of the Arabic Version

Al-Aqeel, Sinaa; AlAujan, Shiekha S; Almazrou, Saja

doi:10.3390/ijerph18147232

Cited by 4 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Medical Consumption Questionnaire evaluates the total direct cost for each type of healthcare provider based on 18 questions related to frequently occurring contacts with healthcare providers (home care, general practitioner, rehabilitation, long-term care, psychologist and paramedical care) 40. The sum of the amount of each resource used will be multiplied by its associated unit costs to evaluate the direct cost for overall healthcare use in the last 3 months.…”

Section: Methodsmentioning

confidence: 99%

Impact of hearing impairment and cochlear implantation on productivity and social well-being in a professionally active but severely hearing-impaired group: protocol of the ‘Hear again, work again’ longitudinal prospective cohort study

et al. 2023

View full text Add to dashboard Cite

IntroductionSevere hearing loss is a sensory deficit with considerable impact on the patient’s daily life and on society. Previous research has established occupational obstacles in professionally active patients with hearing loss. However, studies investigating the impact of severe hearing loss and cochlear implantation (CI) on work performance using a quantitative and longitudinal study design and validated questionnaires are lacking. This study aims to answer the following research question: ‘What is the impact of unilateral and bilateral severe hearing loss and CI on the cost for society, health state, employment, productivity and social well-being?’. We hypothesise hearing impairment to influence work performance. After establishing the impact, we will be able to enhance the support of hearing impaired patients to maintain employed.Methods and analysisA total of 200 professionally active adults between 18 and 65 years old with severe hearing loss will be included for assessment at baseline and reassessment at 3, 6 and 12 months. The following four study groups are included: bilateral severely hearing impaired participants without CI (1) and with CI (2) and unilateral severely hearing impaired participants in acute (3) and chronic (4) setting. The primary outcome of this study is the change in index score on the Work Limitations Questionnaire, which evaluates the degree of limitations and health-related productivity loss. Secondary outcome measures include audiometric and cognitive evaluations and validated questionnaires evaluating employment, work productivity, quality of life and direct healthcare costs. Linear mixed models will assess the evolution in time and the difference in evolution between groups.Ethics and disseminationThis study protocol (project ID 2021-0306) received ethical approval from the ethics committee of the Antwerp University Hospital on 22 November 2021. Our findings will be disseminated by peer-reviewed publications and conference presentations.Trial registration numberNCT05196022.

show abstract

Section: Methodsmentioning

confidence: 99%

Impact of hearing impairment and cochlear implantation on productivity and social well-being in a professionally active but severely hearing-impaired group: protocol of the ‘Hear again, work again’ longitudinal prospective cohort study

et al. 2023

View full text Add to dashboard Cite

show abstract

“… Questionnaire for measuring subjective cognitive functioning. The items are globally related to memory and attention The Cognitive Failure Questionnaire CFQ [ 38 ] Patient’s perception of overall health Euroqol Vertical Visual Analogue Scale EQ VAS, versie 2.0 [ 39 ] Health status: Mobility, Self-care, usual activities, pain/discomfort, anxiety and depression Economic appraisal of health Euroqol-5 Dimensions with 5 Levels Eq-5d-5L Versie 2.0 [ 40 ] Severity of MS Health status Proactive coping iMTA Medical Consumption Questionnaire iMCQ [ 41 ] Effect of work on illness iMTA Productivity Cost Questionnaire iPCQ [ 41 ] MS-Participation and autonomy Impact on participation and autonomy IPA [ 42 ] Self-efficacy The MSSES-Function subscale measures confidence with functional abilities, whereas the MSSES-Control subscale measures confidence with managing symptoms and coping with the demands of illness MS Self-Efficacy Scale MSSES [ 43 ] Self-management of health Information on the disease, dealing with the consequences of chronic disease, active role in consultation, and the extent to which complaints and symptoms can be monitored at home Partners in Health Scale (Working together on health) PIH-NL [ 44 , 45 ] Construct Prems by RMP (eCRF) for patients PREM abbreviation Ref. Satisfaction Patient satisfaction questionnaire Isala PTO [ 46 ] Construct Proms by consultation PROM abbreviation Ref.…”

Section: Methodsmentioning

confidence: 99%

MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial

Hoving

Jongen²,

Evers³

et al. 2022

BMC Neurol

View full text Add to dashboard Cite

Background We designed a new multi-modal version of the MSmonitor, called the MSmonitor-Plus and Video calling Care (MPVC), a self-management and education program with e-health interventions that combines frequent use of specific questionnaires with video calling in treating multiple sclerosis (MS) patients. Objective To assess the effectiveness, cost-effectiveness and feasibility of MPVC compared to care as usual (CAU), with the goal of achieving equal or better quality of life for MS patients and their partners/informal caregivers. Our hypothesis is that by using MPVC, monitoring will become more efficient, that patients’ self-efficacy, quality of life, and adherence to treatment will improve, and that they will be able to live their lives more autonomously. Methods A randomized, parallel-group, open label, non-inferiority trial will be conducted to compare MPVC with CAU in MS patients and their partners/informal caregivers. A total of 208 patients will be included with follow-up measurements for 2 years (at baseline and every 3 months). One hundred four patients will be randomized to MPVC and 104 patients to CAU. Partners/informal caregivers of both groups will be asked to participate. The study will consist of three parts: 1) a clinical effectiveness study, 2) an economic evaluation, and 3) a process evaluation. The primary outcome relates to equal or improved disease-specific physical and mental quality of life of the MS patients. Secondary outcomes relate to self-efficacy, efficiency, cost-effectiveness, autonomy, satisfaction with the care provided, and quality of life of partners/informal caregivers. Discussion The idea behind using MPVC is that MS patients will gain more insight into the individual course of the disease and get a better grip on their symptoms. This knowledge should increase their autonomy, give patients more control of their condition and enable them to better and proactively interact with health care professionals. As the consulting process becomes more efficient with the use of MPVC, MS-related problems could be detected earlier, enabling earlier multidisciplinary care, treatment or modification of the treatment. This could have a positive effect on the quality of life for both the MS patient and his/her partner/informal caregiver, reducing health and social costs. Trial registration NCT05242731 Clinical Trials.gov. Date of registration: 16 February 2022 retrospectively registered.

show abstract

“…Various studies have employed different methods to explore the financial burden of diseases in healthcare systems, depending on the purpose of cost analysis (28)(29)(30). The cost of illness (COI) method is commonly used to evaluate the impact of diseases on populations, considering both direct and indirect costs (25,26,31). The ultimate goal of a COI study is to present objective evidence needed for policymaking, designing, and managing health programs.…”

Section: Introductionmentioning

confidence: 99%

Heart failure: a prevalence-based and model-based cost analysis

Mahmoudi,

Chenaghlou,

Zare

et al. 2023

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

IntroductionHeart failure (HF) imposes a heavy economic burden on patients, their families, and society as a whole. Therefore, it is crucial to quantify the impact and dimensions of the disease in order to prioritize and allocate resources effectively.MethodsThis study utilized a prevalence-based, bottom-up, and incidence-based Markov model to assess the cost of illness. A total of 502 HF patients (classes I–IV) were recruited from Madani Hospital in Tabriz between May and October 2022. Patients were followed up every two months for a minimum of two and a maximum of six months using a person-month measurement approach. The perspective of the study was societal, and both direct and indirect costs were estimated. Indirect costs were calculated using the Human Capital (HC) method. A two-part regression model, consisting of the Generalized Linear Model (GLM) and Probit model, was used to analyze the relationship between HF costs and clinical and demographic variables.ResultsThe total cost per patient in one year was 261,409,854.9 Tomans (21,967.21 PPP). Of this amount, 207,147,805.8 Tomans (17,407.38 PPP) (79%) were indirect costs, while 54,262,049.09 Tomans (4,559.84 PPP) (21%) were direct costs. The mean lifetime cost was 2,173,961,178 Tomans. Premature death accounted for the highest share of lifetime costs (48%), while class III HF had the lowest share (2%). Gender, having basic insurance, and disease class significantly influenced the costs of HF, while comorbidity and age did not have a significant impact. The predicted amount closely matched the observed amount, indicating good predictive power.ConclusionThis study revealed that HF places a significant economic burden on patients in terms of both direct and indirect costs. The substantial contribution of indirect costs, which reflect the impact of the disease on other sectors of the economy, highlights the importance of unpaid work. Given the significant variation in HF costs among assessed variables, social and financial support systems should consider these variations to provide efficient and fair support to HF patients.

show abstract

The Institute for Medical Technology Assessment Productivity Cost Questionnaire (iPCQ) and the Medical Consumption Questionnaire (iMCQ): Translation and Cognitive Debriefing of the Arabic Version

Cited by 4 publications

References 24 publications

Impact of hearing impairment and cochlear implantation on productivity and social well-being in a professionally active but severely hearing-impaired group: protocol of the ‘Hear again, work again’ longitudinal prospective cohort study

Impact of hearing impairment and cochlear implantation on productivity and social well-being in a professionally active but severely hearing-impaired group: protocol of the ‘Hear again, work again’ longitudinal prospective cohort study

MSmonitor-plus program and video calling care (MPVC) for multidisciplinary care and self-management in multiple sclerosis: study protocol of a single-center randomized, parallel-group, open label, non-inferiority trial

Heart failure: a prevalence-based and model-based cost analysis

Contact Info

Product

Resources

About